Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

Frontotemporal dementia (FTD) therapy development is hamstrung by a lack of susceptibility, diagnostic, and prognostic biomarkers. Blood neurofilament light (NfL) shows promise as a biomarker, but studies have largely focused only on core FTD syndromes, often grouping patients with different diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Gendron, Tania F., Heckman, Michael G., White, Launia J., Veire, Austin M., Pedraza, Otto, Burch, Alexander R., Bozoki, Andrea C., Dickerson, Bradford C., Domoto-Reilly, Kimiko, Foroud, Tatiana, Forsberg, Leah K., Galasko, Douglas R., Ghoshal, Nupur, Graff-Radford, Neill R., Grossman, Murray, Heuer, Hilary W., Huey, Edward D., Hsiung, Ging-Yuek R., Irwin, David J., Kaufer, Daniel I., Leger, Gabriel C., Litvan, Irene, Masdeu, Joseph C., Mendez, Mario F., Onyike, Chiadi U., Pascual, Belen, Ritter, Aaron, Roberson, Erik D., Rojas, Julio C., Tartaglia, Maria Carmela, Wszolek, Zbigniew K., Rosen, Howard, Boeve, Bradley F., Boxer, Adam L., Petrucelli, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044101/
https://www.ncbi.nlm.nih.gov/pubmed/35492244
http://dx.doi.org/10.1016/j.xcrm.2022.100607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044101/
https://www.ncbi.nlm.nih.gov/pubmed/35492244
http://dx.doi.org/10.1016/j.xcrm.2022.100607

Ejemplares similares